Clinical Trial Update: FDGL Dose-Finding Study for Diabetic Neuropathy [Phase 2]

View source ↗

Summary

Helwan University conducted a Phase 2 dose-finding study of FDGL for diabetic neuropathy that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• FDGL

Snippet

Sponsor: Helwan University | Conditions: Diabetic Neuropathy | Phase 2 | Status: COMPLETED